Medications for Pulmonary Embolism
43 results
Activase (alteplase)
(Alteplase)Genentech, Inc.
Usage: Activase is indicated for the treatment of acute ischemic stroke, acute myocardial infarction (AMI) to reduce mortality and heart failure incidence, and lysis of acute massive pulmonary embolism with significant obstruction or unstable hemodynamics. Treatment should be initiated quickly, particularly for stroke within 3 hours of symptom onset.
Apixaban (apixaban)
(Apixaban)Macleods Pharmaceuticals Limited
Usage: Apixaban is indicated for reducing stroke and systemic embolism risk in nonvalvular atrial fibrillation, prophylaxis of deep vein thrombosis following hip or knee surgery, and treatment of deep vein thrombosis and pulmonary embolism. It also reduces the risk of recurrent DVT and pulmonary embolism after initial therapy.
Dabigatran etexilate (dabigatran etexilate)
(dabigatran etexilate)Apotex Corp.
Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, preventing their recurrence, and prophylaxis following hip replacement surgery in adult patients.
Dabigatran etexilate (dabigatran etexilate)
(Dabigatran Etexilate)Mylan Pharmaceuticals Inc.
Usage: Dabigatran etexilate capsules are indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating and preventing deep vein thrombosis and pulmonary embolism in adults and pediatric patients aged 8-17, and preventing recurrence of venous thromboembolic events.
Dabigatran etexilate (dabigatran etexilate)
(Dabigatran etexilate)Dr. Reddy's Laboratories Inc.
Usage: Dabigatran etexilate capsules are indicated for reducing stroke risk in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, providing prophylaxis following hip replacement surgery, and treating and preventing venous thromboembolic events in pediatric patients aged 8 to under 18 years.
Dabigatran etexilate (dabigatran etexilate)
(Dabigatran Etexilate)Alembic Pharmaceuticals Limited
Usage: Dabigatran etexilate is indicated for reducing the risk of stroke and systemic embolism in non-valvular atrial fibrillation, treating deep venous thrombosis and pulmonary embolism, preventing recurrence of these conditions, and prophylaxis following hip replacement surgery in adults.
Eliquis (apixaban)
(apixaban)E.R. Squibb & Sons, L.L.C.
Usage: ELIQUIS is indicated for reducing stroke risk in nonvalvular atrial fibrillation, preventing deep vein thrombosis after hip or knee surgery, and treating deep vein thrombosis and pulmonary embolism. It also helps reduce the risk of recurrence of DVT and PE, and treats venous thromboembolism in pediatric patients after initial therapy.
Enoxaparin sodium (enoxaparin sodium)
(Enoxaparin Sodium)Fresenius Kabi USA, LLC
Usage: Enoxaparin sodium injection is indicated for the prophylaxis and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of ischemic complications in unstable angina and non-Q-wave myocardial infarction. Additionally, it aids in treating acute ST-segment elevation myocardial infarction.
Fondaparinux sodium (fondaparinux sodium)
(Fondaparinux Sodium)Sandoz Inc.
Usage: Fondaparinux sodium injection is indicated for the prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip or knee surgery and at-risk abdominal surgery. It is also used for treating acute DVT and acute pulmonary embolism in combination with warfarin sodium.
Fondaparinux sodium (fondaparinux sodium)
(Fondaparinux Sodium)Dr. Reddy's Laboratories Inc.
Usage: Fondaparinux sodium injection is used for the prophylaxis of deep vein thrombosis (DVT) in various surgical patients and for treating acute DVT and pulmonary embolism, in conjunction with warfarin sodium.